8.570
+1,42%
2026-10-19
Fundamental Analysis
54 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +418.3% | +136.9% | 1 / 3 | +51.5% | -3.07 pp | +0.41 pp | +2.2% | 0.97 | 38.54 | 1.559 | +51,5% | 21,9 | +113,4% | 38.54 | 9.67 | +298,6% |
| Pts | 12 | 12 | 4 | 12 | 0 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 8.570 (close price on 2026-10-19)EPS (TTM): 222,4
Financial charts
1.Revenue & growth
VND bn1.559Q2/26
1.Revenue & growth
VND bn1.559Q2/26
2.Profit & growth
VND bn14,1Q2/26
3.Profit mix (Penman)
VND bn65,6Q2/26
4.Margins & cost structure
%6.3%Q2/26
5.Returns & cash cycle
% · days-2.2%Q2/26
6.Earnings quality & cash
VND bn-327Q2/26
7.Asset structure
VND bn3.393Q2/26
8.Funding & debt health
VND bn · times3.393Q2/26
9.Revenue backlog
VND bn51,6Q2/26
10.Valuation
times · %38,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %131Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-3.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26